Thymic neuroendocrine carcinoma Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

1 event

Apr 2016Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas

ECOG-ACRIN Cancer Research Group — PHASE2

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Thymic neuroendocrine carcinoma.
Check the disease page for updates →

Clinical Trial Landscape

No active clinical trials currently recruiting for Thymic neuroendocrine carcinoma.
Search all trials →

Search clinical trials for Thymic neuroendocrine carcinoma →

Recent News & Research

No recent news articles indexed yet for Thymic neuroendocrine carcinoma.
Search PubMed for Thymic neuroendocrine carcinoma →

Browse all Thymic neuroendocrine carcinoma news →

Specialist Network

Top 6 by expertise

Arun Rajan, M.D., M.D

National Cancer Institute (NCI)

📍 BETHESDA, MD

Score 3111 trials

Jennifer Eads

ECOG-ACRIN Cancer Research Group

📍 Kingman, Arizona

Score 81 trial

Armando Santoro, MD

Istituto Clinico Humanitas

Score 619 trials

Jonathan Strosberg, M.D., MD

H. Lee Moffitt Cancer Center and Research Institute

📍 TAMPA, FL

Score 46 trials

Mark Stevens, Phd

Travera Inc

Score 31 trial

Nicola Fazio, MD

IEO

Score 32 trials

View all Thymic neuroendocrine carcinoma specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰